NVO 股價走勢圖
NVO 股票價格預測
Novo Nordisk A/S
$46.63
1.22%
$0.56
截至今日：May 11, 15:43:30 GMT-4
返回
Novo Nordisk A/S (NVO) 股票價格預測
關鍵數據
前收市價
$46.07
開盤價
$46.69
當日範圍
$46.47 - $47.79
52週區間
$35.12 - $81.44
交易量
13.9M
平均成交量
20.3M
股息收益率
--
每股盈餘 (TTM)
3.61
市值
$156.6B
什麼是 Novo Nordisk A/S？
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also offers Saxenda product to treat obesity. The company offers a range of products, including NovoLog/NovoRapid; NovoLog Mix/NovoMix; Prandin/NovoNorm; NovoSeven; Norditropin, and Vagifem. As of December 31, 2016, it marketed its products in over 180 countries. Its regional structure consists of two commercial units: North America and International Operations.
